Delivery Order SPE2DB20D1109-SPE2DB24FN85P
- Not listed
- This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $3,270.58 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. Amerisourcebergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA, valued at...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the provision of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,828.64 and a completion date of July 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The $5,142.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 7, 2025 with a completion date of May 8, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $3,003.51, has a completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $4,370.10 and is a Firm Fixed Price Delivery Order with an ultimate completion date of September 27, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This award is not a set-aside contract. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a prime contractor and leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,828.64, is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialized pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to...
- This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,847.29 and is a firm fixed-price delivery order with a completion date of November 20, 2023. The award was made on November 17, 2023, and there was no set-aside used. Amerisourcebergen Drug Corp is...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the government. The $2,742.93 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN85PDelivery Order
This federal contract award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $2,889.17 and a period of performance through March 22, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 3/21/24 |